vs
科睿唯安（CLVT）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是LifeStance Health Group, Inc.的1.5倍（$585.5M vs $382.2M），LifeStance Health Group, Inc.净利率更高（3.1% vs -6.9%，领先9.9%），LifeStance Health Group, Inc.同比增速更快（17.4% vs -1.4%），科睿唯安自由现金流更多（$78.9M vs $46.6M），过去两年LifeStance Health Group, Inc.的营收复合增速更高（12.8% vs -5.1%）
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
CLVT vs LFST — 直观对比
营收规模更大
CLVT
是对方的1.5倍
$382.2M
营收增速更快
LFST
高出18.8%
-1.4%
净利率更高
LFST
高出9.9%
-6.9%
自由现金流更多
CLVT
多$32.3M
$46.6M
两年增速更快
LFST
近两年复合增速
-5.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $585.5M | $382.2M |
| 净利润 | $-40.2M | $11.7M |
| 毛利率 | 67.2% | — |
| 营业利润率 | 5.2% | 4.7% |
| 净利率 | -6.9% | 3.1% |
| 营收同比 | -1.4% | 17.4% |
| 净利润同比 | 61.3% | 264.1% |
| 每股收益（稀释后） | $-0.06 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLVTLFST
| Q1 26 | $585.5M | — | ||
| Q4 25 | $617.0M | $382.2M | ||
| Q3 25 | $623.1M | $363.8M | ||
| Q2 25 | $621.4M | $345.3M | ||
| Q1 25 | $593.7M | $333.0M | ||
| Q4 24 | $663.0M | $325.5M | ||
| Q3 24 | $622.2M | $312.7M | ||
| Q2 24 | $650.3M | $312.3M |
净利润CLVTLFST
| Q1 26 | $-40.2M | — | ||
| Q4 25 | $3.1M | $11.7M | ||
| Q3 25 | $-28.3M | $1.1M | ||
| Q2 25 | $-72.0M | $-3.8M | ||
| Q1 25 | $-103.9M | $709.0K | ||
| Q4 24 | $-191.8M | $-7.1M | ||
| Q3 24 | $-65.6M | $-6.0M | ||
| Q2 24 | $-304.3M | $-23.3M |
毛利率CLVTLFST
| Q1 26 | 67.2% | — | ||
| Q4 25 | 66.8% | — | ||
| Q3 25 | 65.0% | — | ||
| Q2 25 | 67.2% | — | ||
| Q1 25 | 65.1% | — | ||
| Q4 24 | 65.7% | — | ||
| Q3 24 | 66.2% | — | ||
| Q2 24 | 67.2% | — |
营业利润率CLVTLFST
| Q1 26 | 5.2% | — | ||
| Q4 25 | 6.7% | 4.7% | ||
| Q3 25 | 7.1% | 2.0% | ||
| Q2 25 | 1.1% | -0.9% | ||
| Q1 25 | -3.5% | 0.5% | ||
| Q4 24 | -9.4% | 0.3% | ||
| Q3 24 | 3.5% | 0.0% | ||
| Q2 24 | -36.9% | -5.1% |
净利率CLVTLFST
| Q1 26 | -6.9% | — | ||
| Q4 25 | 0.5% | 3.1% | ||
| Q3 25 | -4.5% | 0.3% | ||
| Q2 25 | -11.6% | -1.1% | ||
| Q1 25 | -17.5% | 0.2% | ||
| Q4 24 | -28.9% | -2.2% | ||
| Q3 24 | -10.5% | -1.9% | ||
| Q2 24 | -46.8% | -7.5% |
每股收益（稀释后）CLVTLFST
| Q1 26 | $-0.06 | — | ||
| Q4 25 | $0.00 | — | ||
| Q3 25 | $-0.04 | — | ||
| Q2 25 | $-0.11 | — | ||
| Q1 25 | $-0.15 | — | ||
| Q4 24 | $-0.27 | — | ||
| Q3 24 | $-0.09 | — | ||
| Q2 24 | $-0.46 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $248.6M |
| 总债务越低越好 | $4.3B | $282.8M |
| 股东权益账面价值 | $4.8B | $1.5B |
| 总资产 | $10.9B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.89× | 0.19× |
8季度趋势，按日历期对齐
现金及短期投资CLVTLFST
| Q1 26 | — | — | ||
| Q4 25 | $329.2M | $248.6M | ||
| Q3 25 | $318.7M | $203.9M | ||
| Q2 25 | $362.6M | $188.9M | ||
| Q1 25 | $354.0M | $134.3M | ||
| Q4 24 | $295.2M | $154.6M | ||
| Q3 24 | $388.5M | $102.6M | ||
| Q2 24 | $376.4M | $87.0M |
总债务CLVTLFST
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $282.8M | ||
| Q3 25 | $4.4B | $284.6M | ||
| Q2 25 | $4.5B | $286.4M | ||
| Q1 25 | $4.5B | $288.2M | ||
| Q4 24 | $4.5B | $290.0M | ||
| Q3 24 | $4.6B | $287.3M | ||
| Q2 24 | $4.6B | $288.0M |
股东权益CLVTLFST
| Q1 26 | $4.8B | — | ||
| Q4 25 | $4.8B | $1.5B | ||
| Q3 25 | $4.9B | $1.5B | ||
| Q2 25 | $5.0B | $1.5B | ||
| Q1 25 | $5.0B | $1.5B | ||
| Q4 24 | $5.1B | $1.4B | ||
| Q3 24 | $5.5B | $1.4B | ||
| Q2 24 | $5.6B | $1.4B |
总资产CLVTLFST
| Q1 26 | $10.9B | — | ||
| Q4 25 | $11.1B | $2.2B | ||
| Q3 25 | $11.2B | $2.1B | ||
| Q2 25 | $11.4B | $2.1B | ||
| Q1 25 | $11.5B | $2.1B | ||
| Q4 24 | $11.5B | $2.1B | ||
| Q3 24 | $12.0B | $2.1B | ||
| Q2 24 | $12.1B | $2.1B |
负债/权益比CLVTLFST
| Q1 26 | 0.89× | — | ||
| Q4 25 | 0.89× | 0.19× | ||
| Q3 25 | 0.90× | 0.19× | ||
| Q2 25 | 0.90× | 0.19× | ||
| Q1 25 | 0.90× | 0.20× | ||
| Q4 24 | 0.88× | 0.20× | ||
| Q3 24 | 0.84× | 0.20× | ||
| Q2 24 | 0.83× | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $134.7M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $78.9M | $46.6M |
| 自由现金流率自由现金流/营收 | 13.5% | 12.2% |
| 资本支出强度资本支出/营收 | 9.5% | 2.9% |
| 现金转化率经营现金流/净利润 | — | 4.93× |
| 过去12个月自由现金流最近4个季度 | $333.9M | $110.0M |
8季度趋势，按日历期对齐
经营现金流CLVTLFST
| Q1 26 | $134.7M | — | ||
| Q4 25 | $159.9M | $57.6M | ||
| Q3 25 | $181.1M | $27.3M | ||
| Q2 25 | $116.3M | $64.4M | ||
| Q1 25 | $171.2M | $-3.1M | ||
| Q4 24 | $141.3M | $62.3M | ||
| Q3 24 | $202.9M | $22.7M | ||
| Q2 24 | $126.2M | $44.1M |
自由现金流CLVTLFST
| Q1 26 | $78.9M | — | ||
| Q4 25 | $89.2M | $46.6M | ||
| Q3 25 | $115.5M | $17.0M | ||
| Q2 25 | $50.3M | $56.6M | ||
| Q1 25 | $110.3M | $-10.3M | ||
| Q4 24 | $59.1M | $56.0M | ||
| Q3 24 | $126.3M | $17.7M | ||
| Q2 24 | $60.3M | $39.0M |
自由现金流率CLVTLFST
| Q1 26 | 13.5% | — | ||
| Q4 25 | 14.5% | 12.2% | ||
| Q3 25 | 18.5% | 4.7% | ||
| Q2 25 | 8.1% | 16.4% | ||
| Q1 25 | 18.6% | -3.1% | ||
| Q4 24 | 8.9% | 17.2% | ||
| Q3 24 | 20.3% | 5.7% | ||
| Q2 24 | 9.3% | 12.5% |
资本支出强度CLVTLFST
| Q1 26 | 9.5% | — | ||
| Q4 25 | 11.5% | 2.9% | ||
| Q3 25 | 10.5% | 2.8% | ||
| Q2 25 | 10.6% | 2.2% | ||
| Q1 25 | 10.3% | 2.2% | ||
| Q4 24 | 12.4% | 1.9% | ||
| Q3 24 | 12.3% | 1.6% | ||
| Q2 24 | 10.1% | 1.6% |
现金转化率CLVTLFST
| Q1 26 | — | — | ||
| Q4 25 | 51.58× | 4.93× | ||
| Q3 25 | — | 25.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Subscription | $397.5M | 68% |
| Re-occurring | $108.6M | 19% |
| Transactional | $79.4M | 14% |
LFST
暂无分部数据
